eGenesis, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2021 | $125 M | No. 3 | $50 to $250 million | equity | SEC | |
| Nov 2019 | $100 M | No. 2 | $50 to $250 million | equity | SEC | |
| Mar 2017 | $13 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
eGenesis, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2021).
SEC Form D · Mar 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Mar 2021
That is all the official record says: eGenesis, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of eGenesis, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 43 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Michael Curtis | Executive officer | Mar 2021 |
| Paul Sekhri | Executive officer | Mar 2021 |
| Peter Hanson | Executive officer | Mar 2021 |
| Sapna Srivastava | Executive officer | Mar 2021 |
| Ariel Jasie | Executive officer | Nov 2019 |
| Kenneth Fan | Executive officer | Nov 2019 |
| Geoff MacKay | Executive officer | Mar 2017 |
| Luhan Yang | Executive officer | Mar 2017 |
| Albert Wiegman | Director | Mar 2021 |
| Isaac Ciechanover | Director | Mar 2021 |
| Julie Sunderland | Director | Mar 2021 |
| Kathleen Fanning | Director | Mar 2021 |
| Lucio Iannone | Director | Mar 2021 |
| Mark Pruzanski | Director | Mar 2021 |
| Paul Sekhri | Director | Mar 2021 |
| Sarah Schlesinger | Director | Mar 2021 |
| Steven Gillis | Director | Mar 2021 |
| Albert L. Wiegman | Director | Nov 2019 |
| Bob More | Director | Nov 2019 |
| Juergen L. Eckhardt | Director | Nov 2019 |
| Lucio L. Iannone | Director | Nov 2019 |
| Boris Nikolic | Director | Mar 2017 |
| Luhan Yang | Director | Mar 2017 |
| Stephen Gillis | Director | Mar 2017 |
| Luhan Yang | Promoter | Mar 2017 |